Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
- 1 November 2002
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 8 (11), 1249-1256
- https://doi.org/10.1038/nm1102-1249
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Inflammation and AtherosclerosisCirculation, 2002
- Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: Results of the randomized investigation by the thoraxcenter of antisense dna using local delivery and ivus after coronary stenting (ITALICS) trialJournal of the American College of Cardiology, 2002
- Origin of neointimal endothelium and α-actin–positive smooth muscle cells in transplant arteriosclerosisJCI Insight, 2001
- Cell cycle‐dependent expression of cyclooxygenase‐2 in human fibroblastsThe FASEB Journal, 2000
- A novel role for the cyclin-dependent kinase inhibitor p27Kip1 in angiotensin II–stimulated vascular smooth muscle cell hypertrophyJCI Insight, 1999
- Proliferation and the Monoclonal Origins of Atherosclerotic LesionsAnnual Review of Medicine, 1998
- Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery.JCI Insight, 1997
- Cell Biology of AtherosclerosisAnnual Review of Physiology, 1995
- Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.JCI Insight, 1994
- Atherosclerosis and the Arterial Smooth Muscle CellScience, 1973